Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma
- First Posted Date
- 2016-05-23
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 33
- Registration Number
- NCT02780310
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
AASUR in High Risk Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Radiation: stereotactic, ultra-fractionated radiotherapy
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 64
- Registration Number
- NCT02772588
- Locations
- 🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
- Conditions
- Breast Cancer
- Interventions
- Procedure: skin punch biopsy
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT02772367
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)
- Conditions
- Liver CancerLiver Metastases
- Interventions
- Procedure: Hepatic trans-arterial embolization (TAE)Device: MRI/CT scanProcedure: biopsyOther: blood draw
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT02772575
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection
- Conditions
- C. Difficile InfectionCancer
- Interventions
- Biological: Fecal Microbiota Transplantation (FMT)
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT02770326
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
- Conditions
- Ovarian Cancer
- Interventions
- Biological: TPIV200Biological: Durvalumab
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT02764333
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center at Rockville, Rockville Centre, New York, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
- Conditions
- LymphomaMantle Cell LymphomaFollicular LymphomaDiffuse Large B Cell Lymphoma
- Interventions
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT02756247
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy
- Conditions
- Breast Cancer
- Interventions
- Behavioral: qualitative interviews with patientsBehavioral: questionnaires
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT02753673
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
- Conditions
- Thoracic SurgeryAtrial Fibrillation in High Risk Patients
- Interventions
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 184
- Registration Number
- NCT02750319
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸University of Washington School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇺🇸Memorial Sloan Kettering Bergen (Consent only), Montvale, New Jersey, United States
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
- Conditions
- Early StageBreast CancerTriple Negative Breast Cancer
- Interventions
- Behavioral: assessment
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT02750358
- Locations
- 🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford, Connecticut, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Coney Island Hospital, Brooklyn, New York, United States